Medtronic Announces FDA Approval Of New Vision 3D Wireless Implantable Cardiac Devices

                   
medicalnewstoday.com     May 15, 2008            

Leading into Heart Rhythm 2008, the pre-eminent worldwide gathering of cardiologists specializing in electrophysiology, Medtronic, Inc. (NYSE: MDT) announced U.S. Food and Drug Administration (FDA) approval of the first wave of cardiac rhythm disease management therapies under the new Vision 3D™... [read full story]                

Full Coverage

Medtronic Gets FDA OK For Implantable Cardiac Devices

marketwatch.com     May 13, 2008          

Medtronic Inc. received Food and Drug Administration approval for its Vision 3D wireless implantable cardiac devices. The Minneapolis implantable medical device manufacturer said the portfolio's first implantable cardioverter-defibrillators and cardiac resynchronization therapy-defibrillators...                

comments

Medtronic gets FDA approval for new defibrillators

ibtimes.com     May 13, 2008          

Medical device maker Medtronic Inc. said Tuesday the Food and Drug Administration approved a new line of wireless cardiac defibrillators. The devices, part of the company's Vision 3D products, automatically transmit data about a patient's heart from the devices to doctors and is accessible via a...                

comments

                   

Timing of Medtronic defibrillator news is no shock

startribune.com     May 14, 2008          

On the eve of a major meeting of doctors, Medtronic and Boston Scientific hoped to garner attention for their new heart devices. Fridley-based Medtronic announced Food and Drug Administration (FDA) approval of a portfolio of heart and cardiac resynchronization defibrillators -- which the company...                

comments

                   

Medtronic 3D Vision Line Gets First FDA Approvals

medgadget.com     May 14, 2008          

Medtronic received FDA approval for the company's wireless implantable defibrillators, the first devices in a product line that also includes pacemakers and resynchronization therapy pacemakers. Leading into Heart Rhythm 2008, the pre-eminent worldwide gathering of cardiologists specializing in...                

comments

                   

Major Sudden Cardiac Arrest Risk Stratification Trials Unveiled

redorbit.com     May 15, 2008          

Posted on: Wednesday, 14 May 2008, 18:00 CDT Medtronic, Inc. (NYSE: MDT), along with several partners, today announced details of several major clinical trials aimed at developing and validating new and innovative risk stratification tools to predict which post-myocardial infarction (MI, or heart...                

comments